This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Masanori Kataoka, Ph.D.
CEO at NATiAS Inc.


Masanori Kataoka is the chief executive officer of NATiAS. He received doctor degree at Nagoya University by the study of liquid phase synthesis of oligonucleotides.

Agenda Sessions

  • Liquid-phase Oligonucleotide Synthesis (LPOS) by Using Blockmer™ - ROOM 103